BrianW.BehmMD

Gastroenterology • Christiansburg, VA

Inflammatory Bowel Disease

Associate Professor, Internal Medicine, University of Virginia School of Medicine

Join to view full profile

Dr. Behm is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Behm's full profile

Already have an account?

Office
110 Akers Farm Rd
Christiansburg, VA 24073
Phone+1 540-381-6000

Fax+1 434-244-9445

Education & Training

University of California (San Francisco)Residency, Internal Medicine, 1999 - 2002
University of Virginia School of MedicineClass of 1999
Cornell university BA, 1991 - 1995

Certifications & Licensure

CA State Medical License 2001 - Present
VA State Medical License 2003 - 2026
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012

Publications & Presentations

PubMed

Clostridioides difficile infection promotes gastrointestinal dysfunction in human and mice post-acute phase of the disease.
Deiziane V S Costa, Natalie Pham, Andrea V Loureiro, Suemin E Yang, Brian W Behm
Anaerobe. 2024-06-01
1 citations
Systemic neutrophil degranulation and emergency granulopoiesis in patients with Clostridioides difficile infection.
Girija Ramakrishnan, Mary K Young, Uma Nayak, Isaura Rigo, Andrea S Marrs
Anaerobe. 2024-06-01
Alanyl-glutamine supplementation forinfection treatment (ACT): a double-blind randomised controlled trial study protocol.
Cirle A Warren, Jae Hyun Shin, Ekta N Bansal, Deiziane V D S Costa, Xin Qun Wang
BMJ Open. 2023-07-19

Press Mentions

3 Leaders in Gastroenterology to KnowFebruary 6th, 2020
P2221 - Polypharmacy May Represent an Independent Risk Factor of Disease Flare in Patients with Ulcerative ColitisOctober 9th, 2018

Professional Memberships